-$0.05 EPS Expected for Trupanion Inc (TRUP) This Quarter
Brokerages expect Trupanion Inc (NYSE:TRUP) to announce earnings of ($0.05) per share for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Trupanion’s earnings. The highest EPS estimate is ($0.04) and the lowest is ($0.05). Trupanion reported earnings per share of ($0.06) in the same quarter last year, which would suggest a positive year over year growth rate of 16.7%. The company is scheduled to issue its next quarterly earnings results after the market closes on Tuesday, November 7th.
According to Zacks, analysts expect that Trupanion will report full year earnings of ($0.09) per share for the current fiscal year, with EPS estimates ranging from ($0.09) to ($0.08). For the next fiscal year, analysts anticipate that the firm will report earnings of $0.01 per share, with EPS estimates ranging from ($0.02) to $0.07. Zacks’ EPS averages are a mean average based on a survey of research firms that cover Trupanion.
Trupanion (NYSE:TRUP) last posted its quarterly earnings results on Tuesday, August 1st. The financial services provider reported ($0.02) EPS for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.01. The business had revenue of $58.30 million during the quarter, compared to analysts’ expectations of $57.58 million. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The business’s quarterly revenue was up 27.3% on a year-over-year basis. During the same period last year, the company posted ($0.03) earnings per share.
A number of analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Trupanion from a “hold” rating to a “buy” rating and set a $29.00 target price on the stock in a research report on Wednesday, October 4th. BidaskClub upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a research note on Friday, October 13th. Cowen and Company reiterated an “outperform” rating and issued a $28.00 price target (up previously from $19.00) on shares of Trupanion in a research note on Wednesday, August 2nd. Stifel Nicolaus reiterated a “buy” rating and issued a $24.00 price target (up previously from $18.00) on shares of Trupanion in a research note on Wednesday, August 2nd. Finally, TheStreet upgraded shares of Trupanion from a “d” rating to a “c-” rating in a research note on Monday, July 17th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $26.50.
COPYRIGHT VIOLATION NOTICE: This article was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/10/22/0-05-eps-expected-for-trupanion-inc-trup-this-quarter.html.
Trupanion (NYSE TRUP) traded up 0.39% during midday trading on Friday, reaching $28.50. 87,496 shares of the company’s stock were exchanged. The company’s market cap is $854.89 million. The firm has a 50-day moving average price of $25.23 and a 200 day moving average price of $21.32. Trupanion has a 12-month low of $13.71 and a 12-month high of $28.96.
In other news, Director Howard E. Rubin sold 100,000 shares of the stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $25.90, for a total value of $2,590,000.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Ian Moffat sold 8,552 shares of the stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $23.20, for a total transaction of $198,406.40. Following the completion of the transaction, the chief operating officer now owns 8,552 shares in the company, valued at approximately $198,406.40. The disclosure for this sale can be found here. Insiders have sold a total of 147,052 shares of company stock worth $3,662,969 in the last 90 days.
Several large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its holdings in Trupanion by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 650,459 shares of the financial services provider’s stock worth $9,249,000 after acquiring an additional 23,419 shares in the last quarter. Baillie Gifford & Co. increased its holdings in Trupanion by 12.3% in the 2nd quarter. Baillie Gifford & Co. now owns 982,373 shares of the financial services provider’s stock worth $21,985,000 after acquiring an additional 107,373 shares in the last quarter. San Francisco Sentry Investment Group CA purchased a new stake in Trupanion in the 2nd quarter worth approximately $2,972,000. Handelsinvest Investeringsforvaltning increased its holdings in Trupanion by 598.3% in the 2nd quarter. Handelsinvest Investeringsforvaltning now owns 209,500 shares of the financial services provider’s stock worth $4,689,000 after acquiring an additional 179,500 shares in the last quarter. Finally, Gerber Kawasaki Wealth & Investment Management purchased a new stake in Trupanion in the 2nd quarter worth approximately $1,300,000.
Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.